Why working with AI in patent matters is not straightforward – for now (part one)

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Why working with AI in patent matters is not straightforward – for now (part one)

Sponsored by

cabinet-oproiu-400px.png
Two robots arguing against a backdrop of scales of justice

In this opening article of a series, Raluca Vasilescu of Cabinet M Oproiu explains her conclusions after experimenting with various AI assistants when responding to office actions in patent applications

Context of the experiments

The use of AI assistants by patent attorneys is tempting as it can shorten the time to prepare submissions.

However, deploying AI assistants in patent drafting is, at least for the author, not recommended, unless the AI assistants are developed or modified in-house to prevent the leaking of information and protect the client’s undisclosed matters until the application is filed.

With regard to responding to office actions, the confidentiality issue is overcome, as the application is already filed.

Typically, an office action deals with novelty and/or inventive step.

Objections based on novelty argue that the application differs from the closest prior art by at least one distinguishing feature that the examiner identifies, typically fewer than those the applicant originally considered. Thus, the first challenge of the patent attorney is to demonstrate that there are more distinguishing features than those considered by the examiner.

Inventive step objections usually claim that the distinguishing features are obvious to a skilled reader. The second challenge of the patent attorney is therefore to demonstrate that the distinguishing features are not obvious.

Description of the experiments

The author considered two office actions for two patent applications in different technical fields. Two AI assistants were used for each case, one of which was internally adapted for use by the firm’s patent attorneys. It is important to note that the internally adapted AI assistant’s memory was deleted after each session.

The purpose of the experiments was to see how much one can rely on the reasoning of the AI assistant. The fixed parameters were:

  • The applications as filed;

  • The prior art; and

  • The office action.

In some experiment rounds, the author expressly mentioned links to the European Patent Convention (EPC) and to the Guidelines for Examination in the European Patent Office (the Guidelines). The variable parameters were the questions addressed to the assistant, further referred to as input.

The input was very scarce in the first experiment round for each office action, along the following lines: “These are the documents, how do you respond to them?”

One of the assistants was of the opinion that the examiner was right in his assessment. The other assistant vaguely defended the application, but the arguments – although written in a very professional style – were not convincing.

There was more input in the second experiment round.

For the initial challenge, a first type of input was along the following lines: “These are the documents, please compare the claims with document D1 and with the examiner’s objection of paragraph xxx and tell me, in light of Article 54 of the EPC, if there are distinguishing features other than those identified by the examiner and, if you find them, how can you defend them.”

Both AI assistants provided some acceptable additional distinguishing features over D1, but not necessarily the same.

A second type of input was along the following lines: “These are the documents, please compare the claims with document D1 and with the examiner’s objection of paragraph xxx. In light of Article 54 of the EPC, is it true that there are no distinguishing features other than those identified by the examiner?”

The internally developed AI assistant – the memory of which was cleared after the first enquiry – provided, to the author’s surprise, arguments that the examiner was right. The other AI assistant, which still had in its memory the arguments against the objection of the examiner, made a vague argument in favour of the examiner, thus contradicting its earlier demonstration.

For the second challenge, referring to inventive step, both AI assistants provided good reasoning, but only if the input was very specific, such as the following: “Please argue why, in light of Article 56 of the EPC and the Guidelines [with a better result if providing the exact chapter], does document D3 teach away from the invention?”

Provisional conclusions on the use of AI in patent matters

Arguing over novelty and inventive step is clearly inherently subjective, be it with or without the use of AI assistants. Therefore, such assistants are useful if they are asked the proper questions and if the response they give is carefully checked by the patent attorney, using their own judgement.

more from across site and SHARED ros bottom lb

More from across our site

The team, comprising two partners and one senior consultant, plans to offer “highly differentiated” services to clients
HGF’s new ownership model frees it from the hiring constraints of traditional partnerships, its CEO told Managing IP
New timeline for 2026 aims to provide clearer guidance to firms and practitioners on the full jurisdictional market view
Attorneys contemplate whether clients using AI for legal guidance is beneficial to attorney-client relationships or more of a nuisance
Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Gift this article